Article 1 to 4 out of 4 concerning PamGene International B.V.
PREMIER Biosoft and PamGene International BV form an alliance(02/23/2007) PREMIER Biosoft International announced an alliance with PamGene International B.V. to develop a software product for designing custom MLPA® oligonucleotide probes for use with PamChip® microarrays.Multiplex Ligation-dependent Probe Amplification ...
PamGene Platform Adopted for Kinase Drug R&D Program(03/13/2006) Collaboration with Johnson & Johnson Pharmaceutical Research & Development PamGene International BV and Johnson & Johnson Pharmaceutical Research & Development (J&JPRD), a division of Janssen Pharmaceutica NV have announced significant progress in their kinase profiling collaboration. After extensive evaluation, PamGene's ...
PamGene Licenses Its Microarray Platform to the University of Nottingham(07/13/2004) Den Bosch, The Netherlands. PamGene International BV has today announced the licensing of its 3-Dimensional, Flow-Through Microarray Platform to Nottingham University, England. This service licence, which includes the sale of a PamGene 4-array ...